New techniques for understanding Huntington's disease

Journal of Neuropsychiatry and Clinical Neurosciences

Volumn 11, Issue 2, 1999, Pages 173-175

  Hurley, Robin A ^a   Jackson, Edward F ^a   Fisher, Ronald E ^a   Taber, Katherine H ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M;

ADULT; ARTICLE; BRAIN PERFUSION; CASE REPORT; CAUDATE NUCLEUS; CLINICAL FEATURE; HUMAN; HUNTINGTON CHOREA; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 0032929210     PISSN: 08950172     EISSN: None     Source Type: Journal    
DOI: 10.1176/jnp.11.2.173     Document Type: Article

References (18)

1. Haddad MS, Cummings JL: Huntington's disease. Psychiatr Clin North Am 1997; 20:791-807
2. Folstein SE: Huntington's Disease: A Disorder of Families. Baltimore, John Hopkins University Press, 1989
3. Jensen P, Fenger K, Bolwig TG, et al: Crime in Huntington's disease: a study of registered offenses among patients, relatives, and controls. J Neurol Neurosurg Psychiatry 1998; 65:467-471
4. Burrus JW, Hurley RA, Taber KH, et al: A functional neuroanatomy of the frontal lobe circuits. Radiology (in press)
5. Walling HW, Baldassare JJ, Westfall TC: Molecular aspects of Huntington's disease. J Neurosci Res 1998; 54:301-308
6. Brinkman RR, Mezei MM, Theilmann J, et al: The likelihood of being affected with Huntington disease by a particular age, for a specific CAG size. Am J Hum Genet 1997; 60:1202-1210
7. 1H NMR spectroscopy studies of Huntington's disease: correlations with CAG repeat numbers. Neurology 1998; 50:1357-1365
8. Harms L, Meierkord H, Timm G, et al: Decreased N-acetylaspartate/choline ratio and increased lactate in the frontal lobe of patients with Huntington's disease: a proton magnetic resonance spectroscopy study. J Neurol Neurosurg Psychiatry 1997; 62:27-30
9. Taylor-Robinson SD, Weeks RA, Bryant DJ, et al: Proton magnetic resonance spectroscopy in Huntington's disease: evidence in favor of the glutamate excitotoxic theory. Mov Disord 1996; 11:167-173
10. Tsai G, Coyle JT: N-acetylaspartate in neuropsychiatric disorders. Prog Neurobiol 1995; 46:531-540
11. Koroshetz WJ, Jenkins BG, Rosen BR, et al: Energy metabolism defects in Huntington's disease and effects of coenzyme Q10. Ann Neurol 1997; 41:160-165
12. 1H NMR spectroscopy. Neurology 1993; 43:2689-2695
13. 1H MRS in the evaluation of Huntington's and Parkinson's diseases. Neurology 1998; 50:1033-1040
14. Harris GJ, Aylward EH, Peyser CE, et al: Single photon emission computed tomographic/blood flow and magnetic resonance volume imaging of basal ganglia in Huntington's disease. Arch Neurol 1996; 53:316-324
15. Sax DS, Powsner R, Kim A, et al: Evidence of cortical metabolic dysfunction in early Huntington's disease by single-photon-emission computed tomography. Mov Disord 1996; 11:671-677
16. Rauch SL, Savage CR: Neuroimaging and neuropsychology of the striatum. Psychiatr Clin North Am 1997; 20:741-768
17. Andrews TC, Brooks DJ: Advances in the understanding of early Huntington's disease using the functional imaging techniques of PET and SPET. Mol Med Today 1998; 4:532-539
18. Dunnett SB, Kendall AL, Watts C, et al: Neuronal cell transplantation for Parkinson's and Huntington's diseases. Br Med Bull 1997; 53:757-776